Google Alert - "EMERALD-1" OR "EMERALD-2" OR "EMERALD-3" AND "durvalumab"のRSSフィード

Google Alert - "EMERALD-1" OR "EMERALD-2" OR "EMERALD-3" AND "durvalumab"のフォロワーはこちらもフォローしています

• ClinicalTrials.gov: Other terms: "NCT03847428" OR "NCT03778957" OR "NCT03298451" OR "NCT04770896" OR "NCT03383458" OR "NCT04039607" OR "NCT03867084" OR "NCT04246177" OR "NCT04777851" OR "NCT03434379" OR "NCT03764293" OR "NCT04521153" OR "NCT04102098" OR clinicaltrials.gov
• ClinicalTrials.gov: Gastric or Gastroesophageal Junction Adenocarcinoma | Other terms: Claudin 18.2 | Phase: 1, 2, 3 | Funded by Industry | Last update posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: Other terms: ("NCT06346392" OR "NCT03505320" OR "NCT06901531" OR "NCT06238843" OR "NCT04592913" OR "NCT02743494" OR "NCT03421288" OR "NCT03221426" OR "NCT04139135" OR "NCT04208347" OR "NCT04006262" OR "NCT04817826" OR "NCT07069712" OR clinicaltrials.gov
• ClinicalTrials.gov: Other terms: ("NCT03875235" OR "NCT04003636" OR "NCT06282575" OR "NCT06467357" OR "NCT04910386" OR "NCT07221253" OR "NCT06109779" OR "NCT05775159" OR "NCT05640791" OR "NCT03478488" OR "NCT03656536" OR "NCT06219941" OR "NCT04466891") | clinicaltrials.gov
• Google Alert - "KEYNOTE-671" OR "AEGEAN" OR "CheckMate-77T" OR "CheckMate-816" OR "TroFuse-019" AND "NSCLC" google.com
• ClinicalTrials.gov: Other terms: "NCT03528694" OR "NCT04165317" OR "NCT03711032" OR "NCT05714202" OR "NCT04752722" OR "NCT04640623" OR "NCT06211764" OR "NCT03775265" OR "NCT04241185" OR "NCT05535218" OR "NCT06623162" OR "NCT06764095" OR "NCT05200988" OR clinicaltrials.gov
• ClinicalTrials.gov: Other terms: "NCT06252753" OR "NCT38849404" | Last update posted in the last 14 days clinicaltrials.gov
• atezolizumab bevacizumab pubmed.ncbi.nlm.nih.gov